Antihyperalgesic effects of ProTx-II, a Nav1.7 antagonist, and A803467, a Nav1.8 antagonist, in diabetic mice
Junzo Kamei(Juntendo University), Hiroko Ikeda(Sumitomo Dainippon Pharma (Japan))
Cited by 23
Related Papers
Lysophosphatidylcholine Activates Extracellular Signal-Regulated Kinases 1/2 Through Reactive Oxygen Species in Rat Vascular Smooth Muscle Cells
|Arteriosclerosis Thrombosis and Vascular Biology|2002|63
Morphine Modulation of Thrombospondin Levels in Astrocytes and Its Implications for Neurite Outgrowth and Synapse Formation
|Journal of Biological Chemistry|2010|61
Exogenous insulin‐like growth factor 1 attenuates cisplatin‐induced muscle atrophy in mice
|Journal of Cachexia Sarcopenia and Muscle|2021|51
Increased 20S Proteasome Expression and the Effect of Bortezomib during Cisplatin-Induced Muscle Atrophy
|Biological and Pharmaceutical Bulletin|2022|23
Increase in neuropeptide Y activity impairs social behaviour in association with glutamatergic dysregulation in diabetic mice
|British Journal of Pharmacology|2020|19